tradingkey.logo
tradingkey.logo

Xilio rises after surprise quarterly profit

ReutersMar 23, 2026 12:45 PM

Shares of drug developer Xilio Therapeutics XLO.O rise 3.18% to $8.11 premarket

Co posts Q4 profit of 81 cents per share, while analysts were expecting loss of $1.68 per share - data compiled by LSEG

Posts Q4 revenue of $13.7 million vs estimate of $7.9 million

Says quarterly revenue rose on higher collaboration and license revenue, driven by its AbbVie collaboration and Gilead license agreement

XLO shares were down over 32% in 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI